Treatment of subclinical hypothyroidism reverses ischemia and prevents myocyte loss and progressive LV dysfunction in hamsters with dilated cardiomyopathy

Wissam Khalife, Yi Da Tang, James A. Kuzman, Tracy A. Thomas, Brent E. Anderson, Suleman Said, Patricia Tille, Evelyn H. Schlenker, A. Martin Gerdes

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Growing evidence suggests that thyroid dysfunction may contribute to progression of cardiac disease to heart failure. We investigated the effects of a therapeutic dose of thyroid hormones (TH) on cardiomyopathic (CM) hamsters from 4 to 6 mo of age. CM hamsters had subclinical hypothyroidism (normal thyroxine, elevated TSH). Left ventricular (LV) function was determined by echocardiography and hemodynamics. Whole tissue pathology and isolated myocyte size and number were assessed. TH treatment prevented the decline in heart rate and rate of LV pressure increase and improved LV ejection fraction. The percentage of fibrosis/necrosis in untreated 4-mo-old CM (4CM; 15.5 ± 2.2%) and 6-mo-old CM (6CM; 21.5 ± 2.4%) hamsters was pronounced and was reversed in treated CM (TCM; 11.9 ± 0.9%) hamsters. Total ventricular myocyte number was the same between 4- and 6-mo-old controls but was reduced by 30% in 4CM and 43% in 6CM hamsters. TH treatment completely prevented further loss of myocytes in TCM hamsters. Compared with age-matched controls, resting and maximum coronary blood flow was impaired in 4CM and 6CM hamsters. Blood flow was completely normalized by TH treatment. We conclude that TH treatment of CM hamsters with subclinical hypothyroidism normalized impaired coronary blood flow, which prevented the decline in LV function and loss of myocytes.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume289
Issue number6 58-6
DOIs
StatePublished - Dec 2005
Externally publishedYes

Fingerprint

Dilated Cardiomyopathy
Left Ventricular Dysfunction
Hypothyroidism
Cricetinae
Muscle Cells
Ischemia
Thyroid Hormones
Left Ventricular Function
Therapeutic Uses
Ventricular Pressure
Thyroxine
Stroke Volume
Echocardiography
Heart Diseases
Thyroid Gland
Fibrosis
Necrosis
Heart Failure
Heart Rate
Hemodynamics

Keywords

  • Blood flow
  • Fibrosis
  • Remodeling
  • Thyroid hormones

ASJC Scopus subject areas

  • Physiology

Cite this

Treatment of subclinical hypothyroidism reverses ischemia and prevents myocyte loss and progressive LV dysfunction in hamsters with dilated cardiomyopathy. / Khalife, Wissam; Tang, Yi Da; Kuzman, James A.; Thomas, Tracy A.; Anderson, Brent E.; Said, Suleman; Tille, Patricia; Schlenker, Evelyn H.; Martin Gerdes, A.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 289, No. 6 58-6, 12.2005.

Research output: Contribution to journalArticle

Khalife, Wissam ; Tang, Yi Da ; Kuzman, James A. ; Thomas, Tracy A. ; Anderson, Brent E. ; Said, Suleman ; Tille, Patricia ; Schlenker, Evelyn H. ; Martin Gerdes, A. / Treatment of subclinical hypothyroidism reverses ischemia and prevents myocyte loss and progressive LV dysfunction in hamsters with dilated cardiomyopathy. In: American Journal of Physiology - Heart and Circulatory Physiology. 2005 ; Vol. 289, No. 6 58-6.
@article{82d10c523af44975b28a71a75874eccc,
title = "Treatment of subclinical hypothyroidism reverses ischemia and prevents myocyte loss and progressive LV dysfunction in hamsters with dilated cardiomyopathy",
abstract = "Growing evidence suggests that thyroid dysfunction may contribute to progression of cardiac disease to heart failure. We investigated the effects of a therapeutic dose of thyroid hormones (TH) on cardiomyopathic (CM) hamsters from 4 to 6 mo of age. CM hamsters had subclinical hypothyroidism (normal thyroxine, elevated TSH). Left ventricular (LV) function was determined by echocardiography and hemodynamics. Whole tissue pathology and isolated myocyte size and number were assessed. TH treatment prevented the decline in heart rate and rate of LV pressure increase and improved LV ejection fraction. The percentage of fibrosis/necrosis in untreated 4-mo-old CM (4CM; 15.5 ± 2.2{\%}) and 6-mo-old CM (6CM; 21.5 ± 2.4{\%}) hamsters was pronounced and was reversed in treated CM (TCM; 11.9 ± 0.9{\%}) hamsters. Total ventricular myocyte number was the same between 4- and 6-mo-old controls but was reduced by 30{\%} in 4CM and 43{\%} in 6CM hamsters. TH treatment completely prevented further loss of myocytes in TCM hamsters. Compared with age-matched controls, resting and maximum coronary blood flow was impaired in 4CM and 6CM hamsters. Blood flow was completely normalized by TH treatment. We conclude that TH treatment of CM hamsters with subclinical hypothyroidism normalized impaired coronary blood flow, which prevented the decline in LV function and loss of myocytes.",
keywords = "Blood flow, Fibrosis, Remodeling, Thyroid hormones",
author = "Wissam Khalife and Tang, {Yi Da} and Kuzman, {James A.} and Thomas, {Tracy A.} and Anderson, {Brent E.} and Suleman Said and Patricia Tille and Schlenker, {Evelyn H.} and {Martin Gerdes}, A.",
year = "2005",
month = "12",
doi = "10.1152/ajpheart.00483.2005",
language = "English (US)",
volume = "289",
journal = "American Journal of Physiology - Endocrinology and Metabolism",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "6 58-6",

}

TY - JOUR

T1 - Treatment of subclinical hypothyroidism reverses ischemia and prevents myocyte loss and progressive LV dysfunction in hamsters with dilated cardiomyopathy

AU - Khalife, Wissam

AU - Tang, Yi Da

AU - Kuzman, James A.

AU - Thomas, Tracy A.

AU - Anderson, Brent E.

AU - Said, Suleman

AU - Tille, Patricia

AU - Schlenker, Evelyn H.

AU - Martin Gerdes, A.

PY - 2005/12

Y1 - 2005/12

N2 - Growing evidence suggests that thyroid dysfunction may contribute to progression of cardiac disease to heart failure. We investigated the effects of a therapeutic dose of thyroid hormones (TH) on cardiomyopathic (CM) hamsters from 4 to 6 mo of age. CM hamsters had subclinical hypothyroidism (normal thyroxine, elevated TSH). Left ventricular (LV) function was determined by echocardiography and hemodynamics. Whole tissue pathology and isolated myocyte size and number were assessed. TH treatment prevented the decline in heart rate and rate of LV pressure increase and improved LV ejection fraction. The percentage of fibrosis/necrosis in untreated 4-mo-old CM (4CM; 15.5 ± 2.2%) and 6-mo-old CM (6CM; 21.5 ± 2.4%) hamsters was pronounced and was reversed in treated CM (TCM; 11.9 ± 0.9%) hamsters. Total ventricular myocyte number was the same between 4- and 6-mo-old controls but was reduced by 30% in 4CM and 43% in 6CM hamsters. TH treatment completely prevented further loss of myocytes in TCM hamsters. Compared with age-matched controls, resting and maximum coronary blood flow was impaired in 4CM and 6CM hamsters. Blood flow was completely normalized by TH treatment. We conclude that TH treatment of CM hamsters with subclinical hypothyroidism normalized impaired coronary blood flow, which prevented the decline in LV function and loss of myocytes.

AB - Growing evidence suggests that thyroid dysfunction may contribute to progression of cardiac disease to heart failure. We investigated the effects of a therapeutic dose of thyroid hormones (TH) on cardiomyopathic (CM) hamsters from 4 to 6 mo of age. CM hamsters had subclinical hypothyroidism (normal thyroxine, elevated TSH). Left ventricular (LV) function was determined by echocardiography and hemodynamics. Whole tissue pathology and isolated myocyte size and number were assessed. TH treatment prevented the decline in heart rate and rate of LV pressure increase and improved LV ejection fraction. The percentage of fibrosis/necrosis in untreated 4-mo-old CM (4CM; 15.5 ± 2.2%) and 6-mo-old CM (6CM; 21.5 ± 2.4%) hamsters was pronounced and was reversed in treated CM (TCM; 11.9 ± 0.9%) hamsters. Total ventricular myocyte number was the same between 4- and 6-mo-old controls but was reduced by 30% in 4CM and 43% in 6CM hamsters. TH treatment completely prevented further loss of myocytes in TCM hamsters. Compared with age-matched controls, resting and maximum coronary blood flow was impaired in 4CM and 6CM hamsters. Blood flow was completely normalized by TH treatment. We conclude that TH treatment of CM hamsters with subclinical hypothyroidism normalized impaired coronary blood flow, which prevented the decline in LV function and loss of myocytes.

KW - Blood flow

KW - Fibrosis

KW - Remodeling

KW - Thyroid hormones

UR - http://www.scopus.com/inward/record.url?scp=28144436302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28144436302&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00483.2005

DO - 10.1152/ajpheart.00483.2005

M3 - Article

VL - 289

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

SN - 0193-1849

IS - 6 58-6

ER -